In the Pharmaceutical Industry there are a large number of drugs which are light sensitive and therefore their formulated products may degrade during manufacturing, storage, and administration. The European Pharmacopoeia prescribes light protection for more than 250 drugs and adjuvants.
This light degradation may result in undesirable effects such as drug potency loss, altered efficacy and adverse biological effects. For example, Ultraviolet light can cause oxidation, hydrolysis and loss of potency to sensitive medicine solutions.
To reduce and/or eliminate this degradation risk, Schematic Engineering Industries provides barrier isolators with lighting solutions to suit the customer requirements.
The photo to the right shows a Barrier Isolator currently in Schematic's production workshop with Monochromatic Light.
For more information on these innovation barrier isolators, please don’t hesitate to contact us.
